Delivery Order SPE2DB22D1041-SPE2DB24FUCF5

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,460.94 firm-fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 medication in 60-count units. The $29,677.67 Firm Fixed Price delivery order contract has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for $3,151.57 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60S medication. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 25, 2024. The contract is a firm fixed-price arrangement with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $19,321.26 for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract, a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, has a firm fixed price and an ultimate completion date of November 30, 2023. The DLA, a defense agency, awarded this contract to support military treatment facilities,...
This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,176.39 firm fixed-price delivery order contract has a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The $77,568.28 firm-fixed-price delivery order contract has an ultimate completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price valued at $4,708.13 and has an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Trelegy Ellipta 200-62.5-25 60s medication to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,273.17 and an ultimate completion date of December 24, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.99 firm fixed-price delivery order contract, with a completion date of February 4, 2025, is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a type of medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,935.54. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication. The contract has a period of performance through May 28, 2024. It is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUCF5
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides Trelegy Ellipta 200-62.5-25 60S medication to the Defense Logistics Agency (DLA). The contract, valued at $9,647.31, is a delivery order with a firm fixed price. The award has an ultimate completion date of June 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:55 AM